Alpine Immune Sciences, Inc. (ALPN) Financial Statements (2024 and earlier)

Company Profile

Business Address 188 EAST BLAINE ST., SUITE 200
SEATTLE, WA 98102
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments237,641162,303105,58140,52052,30381,240
Cash and cash equivalents13,37667,90734,95916,12310,7118,000
Short-term investments224,26594,39670,62224,39741,59273,240
Restricted cash and investments    132  
Receivables70925,323304100237128
Prepaid expense762720615375445389
Deferred costs  352 15477 
Other undisclosed current assets1,8813,3156011,16083791
Total current assets:240,993192,013107,10142,30253,54582,548
Noncurrent Assets
Operating lease, right-of-use asset8,2198,8379,4019,985
Property, plant and equipment1,5841,7161,7851,5521,1961,089
Long-term investments and receivables35,48152,86625,549   
Long-term investments35,48152,86625,549   
Intangible assets, net (including goodwill)      1,453
Intangible assets, net (excluding goodwill)      1,453
Restricted cash and investments254254254254132132
Deferred income tax assets155214  
Total noncurrent assets:45,69363,88736,98911,7911,3282,674
TOTAL ASSETS:286,686255,900144,09054,09354,87385,222
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,28912,7666,3596,8285,993575
Accounts payable4,2863,3495821,5431,716193
Accrued liabilities14,0039,4175,7775,2854,277382
Deferred revenue35,57151,77331,6271,435
Debt 3,3804,6222,5264182,048995
Deferred rent credit     86
Deferred revenue and credits325
Other undisclosed current liabilities756617655   
Total current liabilities:57,99669,77841,1678,6818,1271,895
Noncurrent Liabilities
Long-term debt and lease obligation  14,38919,41715,9382,1554,039
Long-term debt, excluding current maturities  3,3807,6024,5092,1554,039
Liabilities, other than long-term debt49,27050,83021,348  371
Deferred revenue and credits66
Deferred revenue39,18550,83021,348 
Deferred tax liabilities, net 305
Operating lease, liability10,08511,00911,81511,429
Total noncurrent liabilities:49,27065,21940,76515,9382,1554,410
Total liabilities:107,266134,99781,93224,61910,2826,305
Equity
Equity, attributable to parent, including:179,420120,90362,15829,47444,59178,917
Additional paid in capital404,456287,345177,947117,37190,66488,346
Accumulated other comprehensive income (loss)(1,121)(273)5310(13)(59)
Accumulated deficit(223,961)(166,199)(115,866)(87,926)(46,074)(9,384)
Other undisclosed equity, attributable to parent463024191414
Total equity:179,420120,90362,15829,47444,59178,917
TOTAL LIABILITIES AND EQUITY:286,686255,900144,09054,09354,87385,222

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues30,06423,4439,3351,7407051,731
Revenue, net1,731
Gross profit:30,06423,4439,3351,7407051,731
Operating expenses(88,211)(73,302)(38,084)(45,314)(38,535)(16,705)
Operating loss:(58,147)(49,859)(28,749)(43,574)(37,830)(14,974)
Nonoperating income3,1912551,5782,060 6,601
Investment income, nonoperating3,2882592451,248 6,601
Other nonoperating income (expense)(97)(4)1,333812  
Interest and debt expense(476)(816)(775)(338)(319)(152)
Loss from continuing operations before equity method investments, income taxes:(55,432)(50,420)(27,946)(41,852)(38,149)(8,525)
Other undisclosed income from continuing operations before income taxes     1,296542
Loss from continuing operations before income taxes:(55,432)(50,420)(27,946)(41,852)(36,853)(7,983)
Income tax expense (benefit)(2,330)876 366200
Loss from continuing operations:(57,762)(50,333)(27,940)(41,852)(36,487)(7,783)
Loss before gain (loss) on sale of properties:(50,333)(27,940)(41,852)(36,487)(7,783)
Net loss available to common stockholders, diluted:(57,762)(50,333)(27,940)(41,852)(36,487)(7,783)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(57,762)(50,333)(27,940)(41,852)(36,487)(7,783)
Comprehensive loss:(57,762)(50,333)(27,940)(41,852)(36,487)(7,783)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(848)(326)432346(59)
Comprehensive loss, net of tax, attributable to parent:(58,610)(50,659)(27,897)(41,829)(36,441)(7,842)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: